CytomX Therapeutics, Inc. Income Statement
CTMX / Health Care|13 years of annual SEC 10-K data (FY2013-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 13 fiscal years. All figures from audited SEC 10-K filings.
CytomX Therapeutics, Inc. reported $76M in revenue and $17M in net loss for FY2025. Revenue has grown at a 44.9% compound annual rate over the past 12 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.68 (distress zone, below 1.8 threshold)
- Strong profit margin: 23.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $76.2M | $138.1M | $101.2M | $53.2M | $37.3M | $100.4M | $57.5M | $59.5M | $71.6M | $15.0M | $888.0K | $5.1M | $888.0K |
| SG&A Expense | $29.8M | $29.7M | $30.0M | $42.8M | $39.2M | $36.0M | $36.8M | $33.5M | $25.6M | $19.9M | $5.0M | $6.5M | $5.0M |
| R&D Expense | $68.7M | $83.4M | $77.7M | $111.6M | $114.2M | $112.9M | $131.6M | $103.9M | $92.3M | $54.8M | $10.9M | $28.3M | $10.9M |
| Operating Income | -$22.4M | $25.0M | -$6.5M | -$101.3M | -$116.0M | -$48.6M | -$110.9M | -$77.9M | -$46.3M | -$59.6M | -$15.0M | -$29.8M | -$15.0M |
| Interest Expense | - | - | - | - | - | - | - | - | - | $1.7M | $254.0K | $487.0K | $254.0K |
| Income Tax | $238.0K | $224.0K | $3.9M | $0 | $0 | -$13.9M | -$427.0K | $14.3M | -$513.0K | -$19.0K | $10.0K | $10.0K | $10.0K |
| Net Income | -$17.4M | $31.9M | -$569.0K | -$99.3M | -$115.9M | -$32.9M | -$102.2M | -$84.6M | -$43.1M | -$58.9M | -$15.1M | -$30.3M | -$15.1M |
| EPS (Diluted) | - | - | - | - | - | - | - | - | -$1.16 | -$1.63 | -$24.46 | - | -$24.46 |
| Shares Outstanding | 137.9M | 80.1M | 67.3M | 66.2M | 65.4M | 45.5M | 45.5M | 45.1M | 38.5M | 36.5M | 996.5K | 989.5K | 772.3K |
| Operating Margin | -29.3% | 18.1% | -6.4% | -190.6% | -311.0% | -48.4% | -192.9% | -130.9% | -64.6% | -396.1% | -1684.2% | - | -1684.2% |
| Profit Margin | -22.8% | 23.1% | -0.6% | -186.8% | -310.5% | -32.8% | -177.8% | -142.2% | -60.2% | -391.5% | -1705.3% | - | -1705.3% |